Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Institut Pasteur Appoints Isabelle Buckle, EVP, Research Applications and Industrial Partnerships and Pierre Legrain, EVP, Academic Development & Grant Office to Reinforce its Partnership Strategy Between Academia and Private Industry


News provided by

Institut Pasteur

01 Dec, 2014, 09:00 GMT

Share this article

Share toX

Share this article

Share toX

PARIS, December 1, 2014 /PRNewswire/ --

Institut Pasteur, research institute of excellence in science, medicine and public health since 1887, and a network of 32 Institut Pasteur worldwide, announces the appointment of Dr. Isabelle Buckle, as Executive-Vice President Research Applications and Industrial Partnerships Department and Dr. Pierre Legrain, as Executive Vice-President, Academic Development and Grant Office Direction. These two strategic positions were created to strengthen the links between Institut Pasteur research, academia and private industry.  These partnerships will support innovation in international research and education to advance science, medicine and health for the future.

Dr. Isabelle Buckle, PhD in Microbiology,  has 25 years of international scientific, commercial and business experience in biotechnology, forged from her previous roles as Global Vice President Clinical Mass Spectrometry at Bruker Daltonics; CEO of InGen Biosciences (an In Vitro Diagnostics company); Worldwide Business Development Director for Global Big Pharmas accounts at Life Technologies, now part of Thermo Fisher Scientific and Regional Director in charge of European Diagnostic partnerships at Ciphergen Biosystems.  Dr Buckle started her carrier at Pharmacia Biotech, now part of GE.

Dr. Buckle, in her new role at the Institut Pasteur, aims to develop an ambitious, reinforced cooperation with industrial and institutional partners, both in France and internationally, in close working relationships with Institut Pasteur Development and the international Institut Pasteur network. Her goal is to improve the cooperation process to leverage the value of patent-protected inventions accomplished by scientific teams at the Institut Pasteur, on campus or worldwide and support the ambitious entrepreneurship of new companies that exploit the scientific and technological know-how on campus.

Dr. Pierre Legrain, PhD in Genetics, has published over 80 scientific articles and has a solid research and management background. Recently he had the responsibility of Master and PhD students at the Graduate School of Ecole Polytechnique. Until 2012, he coordinated the evaluation of public research in the life sciences at AERES. He joined the CEA (French Alternative Energies and Atomic Energy Commission) in 2003 at the Direction of Biology Department of Joliot-Curie and, later on, managed the CEA Life Sciences Division. Pierre started as Laboratory Director at Institut Pasteur in 1995, where he created and managed the first start-up: Hybrigenics.

Dr Legrain's key role at the newly created Academic Development and Grant Office Department is to foster the development of transversal research programs, some of which concern major human health areas, such as vaccinology, microbiology, oncology and brain science. These programs will involve both Institut Pasteur Campus teams and the entire Institut Pasteur international network. In the initial stages, these programs may be self-financed but they should attract new funding partners in subsequent phases.

The Academic Development and Grant Office Direction will work in close relationship with the  Research Applications and Industrial Partnerships Direction and with the Communication Direction to identify Institut Pasteur future partnerships with French and foreign public funding agencies, industry and private foundations.

"Dr Buckle and Dr Legrain both have excellent educational and management credentials to ensure the future growth of International Institut Pasteur and to support its research, education and public Health missions", said Christian Brechot, President of Institut Pasteur. "We are happy that Isabelle and Pierre have joined us to develop the value of our scientific research with academic and industrial partnerships that is crucial to allow, on the one hand, patients to benefit from our campus and international network innovations and, on the other hand, to fund our research, in the interest of all".

About the Institut Pasteur  

For the past 125 years, scientists from the Institut Pasteur have been on the front line in the fight against major public health challenges worldwide, battling threatening human diseases. While leading the field of infectious diseases, pioneering teams at the Institut Pasteur are also recognized for their excellence in neuroscience, developmental biology, genetics and genomics. Their research efforts have lead to improvements in our understanding of living beings and to the development of new methods for the diagnosis, prevention and treatment of disease. The Institut Pasteur's scientific strategy focuses on developing original and innovative topics, promoting interdisciplinary and multidisciplinary cooperation, and transferring scientific discoveries to applications. To gain new victories in the fight against disease, Institut Pasteur teams have access to all the technological resources they need, to speed up and further improve the quality of their outstanding research.

With an international network of 32 institutes worldwide, the Institut Pasteur plays a key role in the understanding, prevention and fight against a vast number of diseases, particularly infectious diseases. Additionally, the Institut Pasteur works in collaboration with major international players to further progress in the life sciences.

The Institut Pasteur has an international reputation for quality teaching that attracts students from all over the world who come to further their knowledge or top up their degree programs.

The Institut Pasteur's budget relies on funding from four sources: donation, government contributions, business development and research contracts.

Press Contact:
Christine Phan, Institut Pasteur
Tel: +33(0)1-45-68-81-92
Email: christine.phan@pasteur.fr

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.